Noticias de CAPR_US

Noticias del mercado

Últimas noticias sobre CAPR_US — 80 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: CAPR_US ✕ 80 resultados
10/03/2026 CAPR_US — Benzinga
Capricor Therapeutics Stock Jumps As FDA Resumes Deramiocel Review
10/03/2026 CAPR_US — Stock Titan
FDA resumes review of Duchenne drug Deramiocel, sets Aug. 22 deadline
10/03/2026 CAPR_US — Seeking Alpha
Capricorgains FDA reviews rejected cell therapy (CAPR:NASDAQ)
10/03/2026 CAPR_US — GuruFocus ES ← EN
HC Wainwright reitera la calificación de compra de Capricor Therapeutics (C
10/03/2026 CAPR_US — Investing.com
Capricor Therapeutics stock surges on FDA BLA review resumption
10/03/2026 CAPR_US — Traders Union
Capricor Therapeutics, Inc. resumes Deramiocel BLA review as FDA sets August 22, 2026 deadline
10/03/2026 CAPR_US — GuruFocus
FDA Resumes Review of Capricor Therapeutics' (CAPR) Deramiocel A
09/03/2026 CAPR_US — Benzinga
Biotech Stocks Pop After CBER Chief Exit - Moderna (NASDAQ:MRNA)
09/03/2026 CAPR_US — Stock Titan
Rare disease biotech Capricor to detail 2025 results Mar. 12
09/03/2026 CAPR_US — TechStock²
Capricor Therapeutics Stock Rises Ahead of March 12 Update as FDA Watch on Duchenne Drug Builds
06/03/2026 CAPR_US — DirectorsTalk Interviews
Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Eyeing a 96.75% Potential Upside in Biotechnology
06/03/2026 CAPR_US — MarketBeat
Capricor Therapeutics (NASDAQ:CAPR) Trading Up 6.2% - Here's What Happened
05/03/2026 CAPR_US — Stocktwits
Capricor Or Sarepta: Two DMD Stocks Enter A High-Stakes Week – Which One Has More Upside?
03/03/2026 CAPR_US — GuruFocus
Capricor (CAPR) Faces Challenges Amidst Stricter FDA Approval Pr
24/02/2026 CAPR_US — Stock Titan
Duchenne trial to showcase Deramiocel Phase 3 data at 2026 MDA meeting
20/02/2026 CAPR_US — DirectorsTalk Interviews
Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Unveiling a 74% Potential Upside in the Biotech Arena
02/02/2026 CAPR_US — BioWorld News
Phase III wins propel Capricor, Belite and DBV higher in December
30/01/2026 CAPR_US — GuruFocus
TANG CAPITAL MANAGEMENT LLC Acquires Significant Stake in Capric
26/01/2026 CAPR_US — Stock Titan
Tang Capital group reports 6.6% Capricor (NASDAQ: CAPR) ownership on Schedule 13G
26/01/2026 CAPR_US — Stock Titan ES ← EN
Presentaciones CAPR ante la SEC: Capricor Therapeutics Inc Formularios 10-K, 10-Q, 8-K

Página 4 de 4

keyboard_arrow_up